Mirum Pharmaceuticals’ Atebrioz is the third FDA-approved drug for fibrodysplasia ossificans progressiva (FOP), but it brings ...

Affordability is top of mind for executives at AHIP as Americans battle skyrocketing healthcare costs. “We are laser-focused on affordability at AHIP,” said Mike Tuffin, president and CEO of AHIP.

When drug prices are too high for patients, physicians take on additional workload to find solutions. A newly released 2026 ...

As AI technology in healthcare becomes more deeply involved in the complex, high-stakes tasks of diagnosis and treatment ...

Pelago launched a behavioral health platform that integrates substance use, mental health and behavioral addiction care, ...

Novartis is acquiring a Sironax platform technology designed to transport a range of drug modalities across the protective ...

ADARx Pharmaceuticals upsized its IPO and raised additional cash through a private placement with partner AbbVie. Lead ADARx program onvuzosiran is in Phase 3 testing for the rare disease hereditary ...

Hospitals' operating margins fell to 1.4% in July, down from 2.2% in May and June, according to new data from Kaufman Hall.

Eli Lilly’s partnership with InnoCare Pharma follows deals struck this year with other China-based companies. While ...

The next evolution in ADHD therapy needs to focus not only on drug efficacy but also on how treatment aligns with the ...

Healthcare leaders know how to test software. We don't yet have a shared playbook for onboarding agents expected to do a job ...

The Series C funding round was from The General Partnership, Index Ventures, General Catalyst and Andreessen Horowitz.